<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://articlefeeds.nasdaq.com/~d/styles/itemcontent.css"?><rss xmlns:a10="http://www.w3.org/2005/Atom" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0">
  <channel xmlns:nasdaq="http://nasdaq.com/reference/feeds/1.0/">
    <title>Latest Articles about CHTP</title>
    <description />
    <language>EN-US</language>
    <lastBuildDate>Thu, 23 May 2013 14:51:26 -0400</lastBuildDate>
    <atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://articlefeeds.nasdaq.com/nasdaq/symbols?symbol=CHTP" /><feedburner:info uri="nasdaq/symbols" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><item xml:base="http://www.nasdaq.com/article/columbia-wanger-chucks-chelsea-despite-fda-progress-cm235278">
      <guid isPermaLink="false">235278</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6KolUey_qk0/columbia-wanger-chucks-chelsea-despite-fda-progress-cm235278</link>
      <category>Investing</category>
      <title>Columbia Wanger Chucks Chelsea, Despite FDA Progress</title>
      <description>The U.S. Food and Drug Administration (FDA) approved only 35 new drugs in 2011. The discouraging snail's pace of new drug evaluation and approval is enough to turn many pharmaceutical investors&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/6KolUey_qk0" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 10 Apr 2013 03:06:40 Z</pubDate>
      <a10:updated>2013-04-10T00:07:21Z</a10:updated>
      <author>Sally Jones</author>
      <nasdaq:tickers>CHTP</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/columbia-wanger-chucks-chelsea-despite-fda-progress-cm235278</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/encouraging-news-at-chelsea-analyst-blog-cm219955">
      <guid isPermaLink="false">219955</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6BfPVa1Uo9U/encouraging-news-at-chelsea-analyst-blog-cm219955</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Encouraging News at Chelsea - Analyst Blog</title>
      <description>Chelsea Therapeutics International Ltd.  (  CHTP  ) recently announced that it received written guidance from the Director of the Office of New Drugs at the US Food and Drug Administration&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/6BfPVa1Uo9U" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 22 Feb 2013 02:30:01 Z</pubDate>
      <a10:updated>2013-02-21T22:50:46Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>BDSI</nasdaq:tickers>
      <nasdaq:tickers>CEMP</nasdaq:tickers>
      <nasdaq:tickers>CHTP</nasdaq:tickers>
      <nasdaq:tickers>CRL</nasdaq:tickers>
      <nasdaq:tickers>TEVA</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/encouraging-news-at-chelsea-analyst-blog-cm219955</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/zacks-1-rank-additions-for-wednesday-tale-of-the-tape-cm195732">
      <guid isPermaLink="false">195732</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XQonIA9IhZs/zacks-1-rank-additions-for-wednesday-tale-of-the-tape-cm195732</link>
      <category>Investing</category>
      <category>Investing Ideas</category>
      <category>Stocks</category>
      <title>Zacks #1 Rank Additions for Wednesday  - Tale of the Tape</title>
      <description>Here are 5 stocks added to the Zacks #1 Rank ("strong buy") List today:    Acxiom Corp.  (  ACXM  )   Alliance Fiber Optic Products, Inc.  (  AFOP  )   Banner Corp.  (  BANR  )&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/XQonIA9IhZs" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 05 Dec 2012 18:14:01 Z</pubDate>
      <a10:updated>2012-12-05T16:04:01Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ACXM</nasdaq:tickers>
      <nasdaq:tickers>AFOP</nasdaq:tickers>
      <nasdaq:tickers>BANR</nasdaq:tickers>
      <nasdaq:tickers>CHTP</nasdaq:tickers>
      <nasdaq:tickers>CONN</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/zacks-1-rank-additions-for-wednesday-tale-of-the-tape-cm195732</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/zacks-1-rank-additions-for-friday-tale-of-the-tape-cm194554">
      <guid isPermaLink="false">194554</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TpZU4jpL1Pg/zacks-1-rank-additions-for-friday-tale-of-the-tape-cm194554</link>
      <category>Investing</category>
      <category>Investing Ideas</category>
      <category>Stocks</category>
      <title>Zacks #1 Rank Additions for Friday - Tale of the Tape</title>
      <description>Here are 5 stocks added to the Zacks #1 Rank ("strong buy") List today:    Acxiom Corp.  (  ACXM  )   Bioanalytical Systems, Inc.  (  BASI  )   Brown-Forman Corp.  (  BF.B  )&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/TpZU4jpL1Pg" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 30 Nov 2012 18:14:01 Z</pubDate>
      <a10:updated>2012-11-30T14:44:00Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ACXM</nasdaq:tickers>
      <nasdaq:tickers>BASI</nasdaq:tickers>
      <nasdaq:tickers>CHTP</nasdaq:tickers>
      <nasdaq:tickers>CVCY</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/zacks-1-rank-additions-for-friday-tale-of-the-tape-cm194554</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/zacks-1-rank-additions-for-monday-tale-of-the-tape-cm171477">
      <guid isPermaLink="false">171477</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jYNKk0VDcAk/zacks-1-rank-additions-for-monday-tale-of-the-tape-cm171477</link>
      <category>Investing</category>
      <category>Investing Ideas</category>
      <category>Stocks</category>
      <title>Zacks #1 Rank Additions for Monday  - Tale of the Tape</title>
      <description>Here are 5 stocks added to the Zacks #1 Rank ("strong buy") List today:    AZZ Inc.  (  AZZ  )   Berkshire Hathaway Inc.  (  BRK.B  )   Chelsea Therapeutics International Ltd.  (  CHTP&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/jYNKk0VDcAk" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 10 Sep 2012 17:14:01 Z</pubDate>
      <a10:updated>2012-09-10T15:39:40Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>AZZ</nasdaq:tickers>
      <nasdaq:tickers>CCUR</nasdaq:tickers>
      <nasdaq:tickers>CHTP</nasdaq:tickers>
      <nasdaq:tickers>EADSY</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/zacks-1-rank-additions-for-monday-tale-of-the-tape-cm171477</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/zacks-1-rank-additions-for-monday-tale-of-the-tape-cm167277">
      <guid isPermaLink="false">167277</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yLCPVrwNPSM/zacks-1-rank-additions-for-monday-tale-of-the-tape-cm167277</link>
      <category>Investing</category>
      <category>Investing Ideas</category>
      <category>Stocks</category>
      <title>Zacks #1 Rank Additions for Monday  - Tale of the Tape</title>
      <description>Here are 5 stocks added to the Zacks #1 Rank ("strong buy") List today:    Ashland Inc.  (  ASH  )   Auxilio, Inc.  (  AUXO  )   Cedar Realty Trust Inc.  (  CDR  )   Chelsea&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/yLCPVrwNPSM" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 27 Aug 2012 16:33:40 Z</pubDate>
      <a10:updated>2012-08-27T15:36:57Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ASH</nasdaq:tickers>
      <nasdaq:tickers>AUXO</nasdaq:tickers>
      <nasdaq:tickers>CDR</nasdaq:tickers>
      <nasdaq:tickers>CHTP</nasdaq:tickers>
      <nasdaq:tickers>CO</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/zacks-1-rank-additions-for-monday-tale-of-the-tape-cm167277</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/setback-for-chelsea-therapeutics-analyst-blog-cm153985">
      <guid isPermaLink="false">153985</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/g8xUdrXUoCs/setback-for-chelsea-therapeutics-analyst-blog-cm153985</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Setback for Chelsea Therapeutics - Analyst Blog</title>
      <description>Chelsea Therapeutics International, Ltd.  (  CHTP  ) recently suffered a setback when the US Food and Drug Administration (FDA), in a written statement, informed the company that it has to&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/g8xUdrXUoCs" height="1" width="1"/&gt;</description>
      <pubDate>Sat, 07 Jul 2012 02:29:01 Z</pubDate>
      <a10:updated>2012-07-06T23:48:24Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ABT</nasdaq:tickers>
      <nasdaq:tickers>BMY</nasdaq:tickers>
      <nasdaq:tickers>CHTP</nasdaq:tickers>
      <nasdaq:tickers>CRL</nasdaq:tickers>
      <nasdaq:tickers>RA</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/setback-for-chelsea-therapeutics-analyst-blog-cm153985</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/volatility-seller-sets-sights-on-chelsea-cm106395">
      <guid isPermaLink="false">106395</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LpMcP04kH8M/volatility-seller-sets-sights-on-chelsea-cm106395</link>
      <category>Investing</category>
      <category>Options</category>
      <title>Volatility seller sets sights on Chelsea</title>
      <description>Chelsea Therapeutics has been milling sideways for most of the year, but news about the drug developer is starting to get interesting.        On Nov. 17, the Food and Drug Administration approved&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/LpMcP04kH8M" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 02 Dec 2011 13:44:18 Z</pubDate>
      <a10:updated>2011-12-02T10:00:40Z</a10:updated>
      <author>David Russell</author>
      <nasdaq:tickers>CHTP</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/volatility-seller-sets-sights-on-chelsea-cm106395</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/top-10-list-of-unusual-option-activity-cm98182">
      <guid isPermaLink="false">98182</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/O-BDAunTYGY/top-10-list-of-unusual-option-activity-cm98182</link>
      <category>Investing</category>
      <category>Options</category>
      <title>Top 10 list of unusual option activity</title>
      <description>Nearing the halfway mark in today's session, here are the top 10 names showing unusual option activity on tradeMONSTER's LiveAction data system.        Invesco (IVZ): Option volume 2,577 percent&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/O-BDAunTYGY" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 13 Oct 2011 20:16:13 Z</pubDate>
      <a10:updated>2011-10-13T17:16:33Z</a10:updated>
      <author>David Russell</author>
      <nasdaq:tickers>CHTP</nasdaq:tickers>
      <nasdaq:tickers>DAR</nasdaq:tickers>
      <nasdaq:tickers>IVZ</nasdaq:tickers>
      <nasdaq:tickers>KRO</nasdaq:tickers>
      <nasdaq:tickers>MAT</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/top-10-list-of-unusual-option-activity-cm98182</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/top-list-of-unusual-option-activity-cm96231">
      <guid isPermaLink="false">96231</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5v5V0rm-FGg/top-list-of-unusual-option-activity-cm96231</link>
      <category>Investing</category>
      <category>Options</category>
      <title>Top list of unusual option activity</title>
      <description>Nearing the halfway mark in today's session, here are the top names showing unusual option activity on tradeMONSTER's LiveAction data system.        Tanzanian Royalty Exploration (TRX): Option&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/5v5V0rm-FGg" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 28 Sep 2011 20:00:25 Z</pubDate>
      <a10:updated>2011-09-28T17:00:57Z</a10:updated>
      <author>David Russell</author>
      <nasdaq:tickers>AUO</nasdaq:tickers>
      <nasdaq:tickers>CHTP</nasdaq:tickers>
      <nasdaq:tickers>DBC</nasdaq:tickers>
      <nasdaq:tickers>RT</nasdaq:tickers>
      <nasdaq:tickers>TRX</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/top-list-of-unusual-option-activity-cm96231</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/top-10-list-of-unusual-option-activity-cm81089">
      <guid isPermaLink="false">81089</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ok6e-LbpgmQ/top-10-list-of-unusual-option-activity-cm81089</link>
      <category>Investing</category>
      <category>Options</category>
      <title>Top 10 list of unusual option activity</title>
      <description>About halfway through today's session, here are the top 10 names showing unusual option activity on tradeMONSTER's data systems.&amp;#160;        CB Richard Ellis Group (CBG): Options volume&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/Ok6e-LbpgmQ" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 16 Jun 2011 20:34:16 Z</pubDate>
      <a10:updated>2011-06-16T17:34:34Z</a10:updated>
      <author>David Russell</author>
      <nasdaq:tickers>CBG</nasdaq:tickers>
      <nasdaq:tickers>CHTP</nasdaq:tickers>
      <nasdaq:tickers>DPTR</nasdaq:tickers>
      <nasdaq:tickers>EGLE</nasdaq:tickers>
      <nasdaq:tickers>GR</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/top-10-list-of-unusual-option-activity-cm81089</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/chelsea-put-sellers-like-fda-move-cm49965">
      <guid isPermaLink="false">49965</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/o9dLeXHDCMI/chelsea-put-sellers-like-fda-move-cm49965</link>
      <category>Investing</category>
      <category>Options</category>
      <title>Chelsea put sellers like FDA move</title>
      <description>Chelsea Therapeutics is popping on a positive regulatory decision, and traders are pricing in better times for the money-losing drug developer.           optionMONSTER's tracking systems detected&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/o9dLeXHDCMI" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 20 Dec 2010 23:19:49 Z</pubDate>
      <a10:updated>2010-12-20T20:04:49Z</a10:updated>
      <author>David Russell</author>
      <nasdaq:tickers>CHTP</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/chelsea-put-sellers-like-fda-move-cm49965</feedburner:origLink></item>
  </channel>
</rss>
